NEUROPACE INC. - COMMON STOCK

NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

10 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors

09 янв 2023 15:03:00 Источник Nasdaq GlobeNewswire

NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference

21 дек 2022 15:03:00 Источник Nasdaq GlobeNewswire

NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update

08 ноя 2022 15:03:00 Источник Nasdaq GlobeNewswire

NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference

04 ноя 2022 15:03:00 Источник Nasdaq GlobeNewswire

NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022

25 окт 2022 15:03:00 Источник Nasdaq GlobeNewswire

NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference      

23 авг 2022 15:06:00 Источник Nasdaq GlobeNewswire

NeuroPace Reports Second Quarter 2022 Financial Results and Provides a Business Update

11 авг 2022 15:02:00 Источник Nasdaq GlobeNewswire

NeuroPace Announces Distribution Agreement with DIXI Medical USA, Provider of Intracranial Electrodes and Instruments for Neurosurgery

11 авг 2022 15:02:00 Источник Nasdaq GlobeNewswire

NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022

21 июл 2022 15:03:00 Источник Nasdaq GlobeNewswire

NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference

13 май 2022 07:00:00 Источник Nasdaq GlobeNewswire

NeuroPace Reports First Quarter 2022 Financial Results

12 май 2022 15:03:00 Источник Nasdaq GlobeNewswire

NeuroPace to Report First Quarter 2022 Financial Results on May 12, 2022

21 апр 2022 15:03:00 Источник Nasdaq GlobeNewswire

NeuroPace Reports Fourth Quarter & Full Year 2021 Financial Results

10 мар 2022 15:02:00 Источник Nasdaq GlobeNewswire

NeuroPace to Report Fourth Quarter and Full Year 2021 Financial Results and Present at the 11th Annual SVB Leerink Global Healthcare Conference 

27 янв 2022 15:03:00 Источник Nasdaq GlobeNewswire

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Revenue

11 янв 2022 15:03:00 Источник Nasdaq GlobeNewswire

NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference

16 дек 2021 06:00:00 Источник Nasdaq GlobeNewswire

NeuroPace Reports Third Quarter 2021 Financial Results

10 ноя 2021 15:03:00 Источник Nasdaq GlobeNewswire

NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy

10 ноя 2021 15:02:00 Источник Nasdaq GlobeNewswire

NeuroPace to Report Third Quarter 2021 Financial Results on November 10, 2021

20 окт 2021 15:05:00 Источник Nasdaq GlobeNewswire